Solano to leave post as AngioDynamics CTO

A little more than a month after AngioDynamics ($ANGO) reported it had found its new CEO in Joseph DeVivo, Scott Solano, the company's senior VP and CTO, has announced he'll be stepping down effective Oct. 14. Solano served as the company's interim CEO for a short period of time this year following the resignation of Jan Keltjens, who is now chief at Endosense. He joined the company in September 2010 after being recruited by Keltjens, The Business Review reports. 

"My decision to leave AngioDynamics is a personal one," said Solano in a statement. "I believe the Company is well positioned for future growth and wish all of the employees great success in the years ahead."

The announcement comes less than two weeks after the company brought Alan Panzer on board as senior VP and general manager of the company's vascular unit.

- see the AngioDynamics release
- read the story from The Business Review

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.